John Leonard, CFA
Special situations, micro-cap, contrarian, CFA

Mannatech Is Overlooked, Undervalued And Turning Around

Key takeaways

    Mannatech (NASDAQ:MTEX) trades at a ~4x EBITDA multiple due to a lack of analyst coverage, residual concern from the Herbalife battle with Ackman and a history of declining revenue.However signs of a turnaround due to new products, cost cutting and an updated incen...
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.